161 – 170 of 207
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
(
- Contribution to journal › Article
-
Mark
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
2016) In Movement Disorders(
- Contribution to journal › Article
-
Mark
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Alterations of diffusion kurtosis and neurite density measures in deep grey matter and white matter in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Plasma β-amyloid in Alzheimer's disease and vascular disease
(
- Contribution to journal › Article
-
Mark
Author response
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios : better diagnostic markers of Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET.
(
- Contribution to journal › Article
-
Mark
18F-AV1451 pet detects tau pathology in mapt mutation carriers and correlates strongly with immunohistochemistry of tau aggregates
2016) Alzheimer’s Association International Conference 2016 In Alzheimer's and Dementia 12(7 Suppl). p.723-724(
- Contribution to journal › Published meeting abstract
-
Mark
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
(
- Contribution to journal › Article